[Effect of the association of antimitotic agents on cell lines of human adenocarcinoma].
Garcia
P
P
Groupe de recherche sur les interactions des protéines en pharmacologie (GRIPP), faculté de pharmacie, Marseille, France.
Braguer
D
D
Carles
G
G
Briand
C
C
D000230:Adenocarcinoma / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002219:Carbamates / Q000008:administration & dosage; D003110:Colonic Neoplasms / Q000188:drug therapy*; D000077143:Docetaxel; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives; D011719:Pyrazines / Q000008:administration & dosage; D011725:Pyridines / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy*; D043823:Taxoids; D014407:Tumor Cells, Cultured / Q000187:drug effects; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
D002219:Carbamates; D011719:Pyrazines; D011725:Pyridines; D043823:Taxoids; D000077143:Docetaxel; D014747:Vinblastine; C072383:canertinib dihydrochloride; D017239:Paclitaxel; D000077235:Vinorelbine
Action de l'association d'agents antimitotiques sur des lignées d'adénocarcinome humain.